BioPharma

25 May, 2026 | Monday | News

Lupin Limited Enters China Market With Approval For Paediatric Oseltamivir Oral Suspension

Global pharmaceutical company Lupin Limited announced that China's National Medical Products Administration has approved the shortened marketing authorization application for oseltamivir phosphate submitted by ...

Lab

26 May, 2026 | Tuesday | News

Beckman Coulter Life Sciences Commercialises Echo 650 Plus Series For Next Generation Acoustic Liquid Handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, has announced the commercial release of the Echo 650 Plus Series acoustic liquid handlers. The latest ...

BioTech

21 May, 2026 | Thursday | News

Agilent And A*STAR’s NATi Partner To Advance Next Generation Oligonucleotide Therapeutics Research

Agilent Technologies Inc.  announced a two-year research  collaboration agreement with Singapore’s Nucleic Acid Therapeutics Initiative (NATi), hosted by Agency  for Science, Technology and...

Contract Services

27 May, 2026 | Wednesday | News

WuXi Vaccines Secures Second ANVISA GMP Certification To Accelerate Brazil Dengue Vaccine Manufacturing

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that its drug substance facility (MFG23) located in Suzhou ...

Consumer Health

27 May, 2026 | Wednesday | News

Gilead Sciences Secures First FDA Approval For Hepcludex In Chronic Hepatitis Delta Virus Treatment

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chroni...

Medtech

27 May, 2026 | Wednesday | News

Stryker Launches Pangea Plating System In Europe To Advance Fracture Fixation Workflows

Stryker (NYSE:SYK), a global leader in medical technologies, announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns. Prof. Ale...

Cell & Gene

26 May, 2026 | Tuesday | News

Scribe Therapeutics Gains Australian Clearance To Begin First Human Trial Of STX 1150 For Hypercholesterolemia

Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and dura...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close